This week's note reviews guidance from CMS on how to report the new 340B modifiers and discusses how hospitals can create systems and processes to ease implementation of new billing requirements associated with the 340B changes.
This week’s Medicare updates include corrections to the OPPS final rule, clarification of Medicare’s policy regarding texting of patient information between healthcare providers, revisions to rural health clinic guidance, and more!
If ICD-10-CM/PCS is used to its full potential, it will provide greater detail and a more accurate depiction of patient severity. This level of detail is expected to provide more information about the relationship between a provider’s performance and the patient’s condition.
CMS' 340B FAQ reviews modifiers -JG (drug or biological acquired with 340B drug pricing program discount) and -TB (drug or biological acquired with 340B drug pricing program discount, reported for informational purposes) and requires 340B hospitals to report modifiers even on drugs that are not subject to the discount policy.
